Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
MR imaging and cognitive correlates of relapsing-remitting multiple sclerosis patients with cerebellar symptoms.
Epileptic Seizures in Early-onset Multiple Sclerosis.
Fatigue is associated with poor sleep in people with multiple sclerosis and cognitive impairment.
A simple test of choice stepping reaction time for assessing fall risk in people with multiple sclerosis.
[Autonomic nervous system alteration in multiple sclerosis patients with urinary symptoms. Clinical, urodynamic and cardiovascular study].
Spasticity in multiple sclerosis: results of a patient survey.
Programming Hippocampal Neural Stem/Progenitor Cells into Oligodendrocytes Enhances Remyelination in the Adult Brain after Injury.
Efficacy and safety of FTY720 in patients with relapsing multiple sclerosis
Progesterone alleviates neural behavioral deficits and demyelination with reduced degeneration of oligodendroglial cells in cuprizone-induced mice.
Risk of relapse phenotype recurrence in multiple sclerosis.
Age and the role of restricted activities in adjustment to disability related pain.
A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort.
Imaging Cortical Damage and Dysfunction in Multiple Sclerosis.
Triptolide with Potential Medicinal Value for Diseases of the Central Nervous System.
Clinical and pathological features of acute optic neuritis in Chinese patients.
Efficacy and safety of cutting balloons for the treatment of obstructive lesions in the internal jugular veins.
Body fluid biomarkers for multiple sclerosis-the long road to clinical application.
Progress of mesenchymal stem cell therapy for neural and retinal diseases.
Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders?
Axons are injured by antigen-specific CD8(+) T cells through a MHC class I- and granzyme B-dependent mechanism.
Spinal cord imaging in multiple sclerosis: Filling the gap with the brain.
Alemtuzumab for relapsing-remitting multiple sclerosis.
Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients.
Current and emerging therapies in multiple sclerosis: a systematic review.
Pages
« first
‹ previous
…
269
270
271
272
273
274
275
276
277
…
next ›
last »